Stay updated on T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial
Sign up to get notified when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.

Latest updates to the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page
- Check5 days agoChange DetectedThe page now displays Revision: v3.3.3, and the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedMinor revision label updated from v3.2.0 to v3.3.2 in the record history, a technical metadata change that does not affect study data or page functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedThe funding/operating status notice banner was removed from the page. This does not affect the study record history or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check55 days agoChange Detected- A new version was posted on 2024-08-22 with updates to Study Status, Recruitment Status, and Outcome Measures.SummaryDifference0.1%

- Check84 days agoChange DetectedCore content updated to v3.2.0 with a government-operating-status notice and a removal of the previous v3.1.0 marker.SummaryDifference11%

- Check91 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.